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The ankyrin repeat domain-55 (ANKRD55) gene contains intronic single nucleotide
polymorphisms (SNPs) associated with risk to contract multiple sclerosis, rheumatoid
arthritis or other autoimmune disorders. Risk alleles of these SNPs are associated
with higher levels of ANKRD55 in CD4+ T cells. The biological function of ANKRD55
is unknown, but given that ankyrin repeat domains constitute one of the most
common protein-protein interaction platforms in nature, it is likely to function in
complex with other proteins. Thus, identification of its protein interactomes may
provide clues. We identified ANKRD55 interactomes via recombinant overexpression
in HEK293 or HeLa cells and mass spectrometry. One hundred forty-eight specifically
interacting proteins were found in total protein extracts and 22 in extracts of sucrose
gradient-purified nuclei. Bioinformatic analysis suggested that the ANKRD55-protein
partners from total protein extracts were related to nucleotide and ATP binding,
enriched in nuclear transport terms and associated with cell cycle and RNA, lipid and
amino acid metabolism. The enrichment analysis of the ANKRD55-protein partners
from nuclear extracts is related to sumoylation, RNA binding, processes associated
with cell cycle, RNA transport, nucleotide and ATP binding. The interaction between
overexpressed ANKRD55 isoform 001 and endogenous RPS3, the cohesins SMC1A
and SMC3, CLTC, PRKDC, VIM, β-tubulin isoforms, and 14-3-3 isoforms were validated
by western blot, reverse immunoprecipitaton and/or confocal microscopy. We also
identified three phosphorylation sites in ANKRD55, with S436 exhibiting the highest
score as likely 14-3-3 binding phosphosite. Our study suggests that ANKRD55 may
exert function(s) in the formation or architecture of multiple protein complexes, and
is regulated by (de)phosphorylation reactions. Based on interactome and subcellular
localization analysis, ANKRD55 is likely transported into the nucleus by the classical
nuclear import pathway and is involved in mitosis, probably via effects associated with
mitotic spindle dynamics.
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INTRODUCTION
An intronic single nucleotide polymorphism (SNP, rs6859219)
in the ankyrin repeat domain protein-55 (ANKRD55) gene
emerged originally as risk factor for rheumatoid arthritis (RA)
from a meta-analysis of genome-wide association studies (1–3).
We demonstrated that this SNP constitutes, as well, a genetic
risk factor for multiple sclerosis (MS) (4), and subsequently
we validated this association with genome-wide significance
(5). A proxy of rs6859219 (r2 = 0.9, D’ = 1), rs71624119,
was also associated with MS in a comprehensive fine-mapping
of autoimmune disease related genomic regions (6). Further
studies have underscored pleiotropy of ANKRD55 by linking
SNPs in this locus to Crohn’s Disease (7, 8), type 1 diabetes
(9), juvenile idiopathic arthritis (10), celiac disease (11) and
inflammatory myopathies (polymyositis and dermatomyositis)
(12, 13), as well as post-traumatic stress disorder (14), cognitive
decline in Alzheimer’s disease (15), and type 2 diabetes (16, 17).
Rs6859219 is significantly associated with expression levels of
three ANKRD55 transcripts, i.e., Ensembl (GRCh37.p13 Human
Genome Assembly) full-length protein isoform 001, shorter
protein isoform 005 and non-coding transcript 007 in PBMCs,
and 001 and 005 in CD4+ T cells (18), and acts thus as a cis-
expression quantitative trait locus (cis-eQTL). Rs71624119 (19)
as wells as rs10065637 (20), a perfect proxy of rs6859219, were
independently identified as cis-eQTLs for ANKRD55 expression,
the latter so by means of multiple tagging probes. The risk
alleles of associated eQTL SNPs such as rs6859219, rs71624119
and rs10065637 are shared among autoimmune diseases and
are associated with higher expression of ANKRD55 in CD4+ T
lymphocytes (18–20). Thus, ANKRD55 appears as the nearest
annotated gene affected by the risk eQTL SNP rs6859219 or
its proxies that emerged from GWAS on various autoimmune
diseases. Notwithstanding these strong indications for a role
of ANKRD55 gene products in autoimmune pathogenesis,
the biological function of ANKRD55 remains unclarified.
Bioinformatic inspection of ANKRD55 does not provide clues as
to its function beyond the presence of nine ankyrin repeats (ARs)
in isoform 001, of which only the last is shared with isoform 005.
ARs are 30–34 residue sequence motifs that represent one of the
most common, modular, protein–protein interaction motifs in
nature (21). They are found in proteins with diverse functions
involved in processes such as transcription, cell cycle regulation,
cytoskeletal integrity, inflammatory response, development, cell–
cell signaling, and various transport phenomena (22, 23). The
involvement of ankyrin repeat proteins in targeting, correct
orientation and mechanical stabilization of membrane proteins
to specific compartments within the endoplasmic reticulum
(ER) and plasma membrane is well-documented (24). Various
biologically important proteins including the family of INK4
tumor suppressors, p15, p16, p18, and p19, the signaling protein
Notch and the NF-κB inhibitor IκB, as well as 53BP2, a regulator
of the tumor suppressor p53, all contain ankyrin repeats (22).
Ankyrin repeat motifs comprise typically a β-turn and two anti-
parallel α-helices. In elucidated complexes, the β-turn and the
first α-helix mediate the interactions with the target, and varying
numbers of neighboring repeats partake in binding (25–27).
These observations support a role for the ankyrin repeat as a
versatile scaffold for protein–protein interactions (PPIs) (21),
with reported binding affinities of natural ankyrin repeat proteins
for their partners occurring in the low nanomolecular range
(28). Based on its ankyrin repeats, ANKRD55 is thus likely to
take part in interactions with diverse proteins. In this study
we used a proteomics-based interactome approach in order to
identify partners of ANKRD55 in purified complexes. Using this
approach, protein partners whose individual roles in the cell have
already been documented, were identified, and these thus shed
light on the pathways and processes in which ANKRD55 is active.
MATERIALS AND METHODS
Cell Culture
HEK293 and HeLa cell lines were maintained in Dulbecco’s
Modified Eagle’s medium (DMEM) supplemented with 10%
inactivated fetal bovine serum (FBSi) and 2mM L-glutamine (all
from Sigma-Aldrich).
DNA Constructs and Cloning Procedures
pCMV6 containing TrueORF Gold Expression validated cDNA
clone including the C-terminal DDK-myc tagged ORF of human
ANKRD55 transcript 001 (NM_024669; Cat. No. RC221211)
was purchased from OriGene. Human ANKRD55 transcript
005 coding sequence was amplified by PCR from pCR-BluntII-
TOPO clone IRCMp5012E115D (Source Bioscience) with
specific primers including restriction sites from Integrated
DNA Technologies (IDT) using Pfu DNA Polymerase (Agilent
Technologies) following manufacturer’s protocol. Primers used:
ATTCGCGATCGCCATGGACAGCAACCTG (005 SgfI Fw),
ACCACGCGTATTTTCATCACTGGTGGGGTTGGCAGA
(005 MluI Rv). The cycling conditions were set to initial
denaturation at 94◦C 45 s, followed by 30 cycles of denaturation
at 94◦C 45 s, annealing at 50◦C 45 s and extension at 72◦C 1min
30 s and a final extension at 72◦C for 10min. The PCR product
size was verified by agarose gel electrophoresis, and the products
were purified using GeneJET Gel Extraction and DNA Cleanup
Micro Kit (Thermo Fisher Scientific) following manufacturer’s
protocol. Amplified product was digested using SgfI and MluI
restriction enzymes (New England Biolabs) and verified by
agarose gel electrophoresis. Purified insert was ligated with
pCMV6 vector digested with the same enzymes using T4 ligase
(New England Biolabs). Individual colonies were screened by
colony PCR and double digestion to identify those that contain
the insert and confirmed by Sanger sequencing.
ANKRD55 Expression Analysis and
Immunoprecipitation
HEK293 and HeLa cells were cultured in T75 flasks (Sigma-
Aldrich) and transfected with FLAG/myc ANKRD55 isoforms
001 or 005 using MACsfectin Reagent (Miltenyi Biotec)
according to manufacturer’s protocol and incubated for
48 h. Wherever applicable, cells were cross-linked using the
membrane-permeable thiol-cleavable homobifunctional cross-
linker dithiobis[succinimidyl propionate] (DSP;Thermo Fisher)
dissolved in dimethyl sulfoxide. The cells were incubated in
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PBS supplemented with 100µg/ml of DSP for 30min, with
gentle vortexing every 5min. Reactions were quenched by
adding 1M Tris-HCl pH 7.5 to final concentration of 50mM
15min at room temperature (RT). For analysis of recombinant
ANKRD55 isoform expression, HeLa and HEK293 were
fractionated into different subcellular compartments following
the protocol from Horton and Holden (29). FLAG-ANKRD55
immunoprecipitation (IP) was carried out from nuclear extracts
obtained by sucrose gradient centrifugation (30); membranous
organelles from subcellular fractionation and total protein
extracts using lysis buffer (50mM NaH2PO4, 300mM NaCl, 1%
triton X-100 and 1% cOmplete EDTA-free protease inhibitor
cocktail pH adjusted to 8.0) or RIPA buffer (50mM Tris-HCl,
pH 7.5, 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate
and 0.1% SDS, 1 U/ml Benzonase and 1% cOmplete EDTA-free
protease inhibitor cocktail). Part of the lysates were kept as
input controls. For full interactome analysis, ANKRD55 IP
was done from nuclear extracts lysed with RIPA buffer and
total protein extracts using lysis buffer. Both buffers included
phosphatase inhibitors (1mM sodium pervanadate, 5mM
beta-glycerophosphate and 5mM NaF). Part of the lysates were
kept as input controls. Protein concentration was estimated
using BCA protein assay kit (Pierce). For nuclear enrichment
by sucrose gradient centrifugation, cells were washed three
times with PBS and resuspended in ice-cold sucrose buffer I
(0.32M sucrose, 3mM CaCl2, 2mMmagnesium acetate, 0.1mM
EDTA, 10mM Tris-HCl pH 8.0, 1mM DTT, 0.5% NP-40) in
a 50-ml tube. A small aliquot of cells was examined with a
phase-contrast microscope to ensure that they were uniformly
lysed. Sucrose buffer II (2M sucrose, 5mM magnesium acetate,
0.1mM EDTA, 10mM Tris-HCl pH 8.0, 1mM DTT) was added
to 50ml polypropylene centrifuge tubes for JA-20 rotor (sucrose
cushion). Nuclei mixture were carefully layered onto the sucrose
cushion, the gradient was completed with sucrose buffer I to
have the same volume and centrifuged for 45min at 30,000×
g and 4◦C in Beckman Coulter J2-MC High Speed Centrifuge.
The supernatant was carefully removed, and nuclei were lysed
with RIPA buffer. For the IP of ANKRD55 isoforms together
with their binding partners, ANKRD55 and control samples
were incubated with Anti-DDK G1 mouse monoclonal antibody
coupled to the resin (cat.no. L00432; Genscript) at 4◦C overnight
(o/n), on rotating wheel. After incubation, resin was washed
six times with washing buffer containing 50mM Tris-HCl and
150mM NaCl, pH adjusted to 7.4 (phosphatase inhibitors were
included for interactome analysis) and ANKRD55 001 complexes
were eluted using acidic elution buffer (0.1M glycine, 0.15M
NaCl and 0,5% SDS pH 2).
Interactome Analysis
In-gel Tryptic Digestion
Immunoprecipitated samples were separated by SDS-PAGE on
6% or 10% gels and stained with Pierce Silver Staining kit or
SYPRO Ruby Protein Gel Stain (both from Thermo Fisher)
according to manufacturer’s protocol. Either selected protein
bands from silver stained gels were excised, or entire lanes from
SYPRO Ruby-stained gels were cut into ten contiguous pieces
(done for both the ANKRD55 001 and control lanes). These
gel slabs were then cut into small pieces and washed in Milli-Q
water. Reduction and alkylation was achieved by incubation with
dithiothreitol (DTT, 10mM in 50mM ammonium bicarbonate)
at 56◦C for 20min, followed by incubation in iodoacetamide (IA,
50mM in 50mM ammonium bicarbonate) for another 20min,
in the dark. Gel pieces were dried and incubated with trypsin
(12.5µg/mL, in 50mM ammonium bicarbonate) for 20min on
ice. After rehydration, the trypsin supernatant was discarded;
gel bands were covered with 50mM ammonium bicarbonate
and incubated overnight at 37◦C. After digestion, supernatant
with digested peptides was recovered. Acidic peptides were
further extracted from the gel with TFA 0.1% and pooled with
the first supernatant. Digested peptides were dried in a RVC2
25 SpeedVac concentrator (Christ). Peptides were resuspended
in 0.1% FA and sonicated for 5min prior to their nano LC
MS/MS analysis.
NanoLC-MS/MS and Data Analysis
Peptide mixtures obtained from trypsin digestion were separated
by online nanoLC and analyzed by electrospray tandem
mass spectrometry. Peptide separation was performed on
a nanoAcquity UPLC system (Waters) connected to an
LTQ Orbitrap XL mass spectrometer (Thermo Electron).
Approximately 40% of each sample was loaded onto a Symmetry
300 C18 UPLC Trap column, 180µm × 20mm, 5µm (Waters).
The precolumn was connected to a BEH130 C18 column, 75µm
× 200mm, 1.7µm (Waters) equilibrated in 3% acetonitrile
and 0.1% FA, and peptides were eluted at 300 nl/min using
a 60min linear gradient of 3–50% acetonitrile directly onto
the nanoelectrospray ion source (Proxeon Biosystems). The
mass spectrometer automatically switched between MS and
MS/MS acquisition in DDA mode. Survey full scan MS
spectra (m/z 400–2,000) were acquired in the orbitrap with
a resolution of 30,000 at m/z 400. The 6 most intense ions
were sequentially subjected to collision-induced dissociation
(CID) fragmentation in the linear ion trap. Precursors with
charge states of 2 and 3 were specifically selected for CID.
Collision-energy applied to each peptide was automatically
normalized as a function of the m/z and charge state. Analyzed
peptides were excluded for further analysis during 30 s using
dynamic exclusion lists. Searches were performed using Mascot
Search engine (Matrix Science) on Proteome Discoverer 1.2.
software (Thermo Electron). Carbamidomethylation of cysteines
as fixed modification, oxidation of methionines as variable
modification, 10 ppm of peptide mass tolerance, and 0.5 Da
fragment mass tolerance were adopted as search parameters. Two
missed cleavages were allowed. Spectra were searched against
a UNIPROT/Swissprot database restricted to Homo sapiens.
A false discovery rate estimation procedure was applied for
peptide identification (FDR <1%). Proteins identified with at
least two peptides passing that cutoff were considered for further
discussion. For interactome analysis, three replicates were run for
each sample type, and a spectral counting approach was carried
out in order to select specifically enriched proteins. This approach
relies on the counting of theMS/MS spectra matching to a certain
protein (31). The comparison of this value for a certain protein in
two different samples provides an idea of its putative differential
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abundance. In our case, proteins with an ANKRD55 IP/Negative
Ctrl IP spectral count ratio >5 in 3/3 replicates were selected for
further analysis and discussion. In order to determine the relative
abundance of each protein in each of the samples, a Normalized
Spectral Abundance Factor (NSAF) approach was carried out
(32). The spectral counts for a protein were normalized to its
length and further expressed as a % of the total of normalized
spectral counts present in that particular sample.
Phosphopeptide Enrichment
To enrich for phosphorylated peptides, titanium dioxide
chromatography was performed essentially as described by
Rigbolt et al. (33) with some modifications. Briefly, an equal
volume of Titansphere material (GL Sciences) was mixed with
a buffer containing 80% ACN / 1% TFA / 0.6M glycolic acid.
The slurry was incubated for 20min at RT with end-over-end
rotation. Sample buffer was adjusted to a final concentration
of 60% ACN / 1% TFA before incubation with the beads.
Titansphere beads were added to the sample in a 0.6mg TiO2
/ 100 peptide µg proportion and mixed 20min at RTwith end-
over-end rotation. Finally, Titansphere material with bound
phosphopeptides was washed three times with 150 µl 60%
ACN / 1% TFA and transferred on top of a C8 disc (Empore)
placed in 200 µL pipette-tip. Phopshopeptide samples were
sequentially eluted using a buffer containing 5% NH4OH and a
buffer containing 25% ACN / 10% NH4OH, dried in a RVC2 25
SpeedVac concentrator (Christ), and resuspended in 2% ACN /
0.3% TFA before nano LC MS/MS analysis.
Functional and Pathway Analysis
The DAVID tool from the NIH (https://david.ncifcrf.gov/) (34)
was used for Gene Ontology (GO) enrichment analysis. Results
from the functional annotation clustering were used to select
the interesting GO terms, and only results with p < 0.05 for
the modified Fisher’s test were considered. Ingenuity Pathway
Analysis was used for more detailed characterization of the
molecular events lying behind the differential protein patterns
under analysis. The calculated p-values determine the probability
that the association between proteins in the dataset and a
given canonical pathway or upstream regulator is explained by
chance alone, based on a Fisher’s exact test (p-value < 0.05
considered significant).
Validation of ANKRD55 Partners
Validation by Reverse IP
HEK293 cells were transfected with the ANKRD55 001 vector
construct using MACSfectin Reagent (Milteny Biotec), or left
untransfected. Twenty-four hours later cells were collected
and lysed in RIPA buffer (50mM Tris-HCL, pH 7.5, 150mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and 1X
cOmplete EDTA-free protease inhibitor cocktail) for 30min on
ice. 0.1ml of cell lysates were immunoprecipitated overnight
in a rotating wheel at 4◦C with 3 µg of anti-14-3-3 epsilon
rabbit polyclonal (Cat. No. 11648-2AP), 3 µg of anti-RPS3 rabbit
polyclonal (Cat. No. 11990-1-AP), 3 µg of IgG control rabbit
polyclonal (Cat. No. 30000-0-AP), 5 µg of anti-TUBB antibody
mouse monoclonal (Cat. No. 66240-1-Ig) or 5 µg of IgG control
mouse polyclonal (Cat. No. B900620), all from Proteintech. Next,
20 µl of protein A resin (Cat. No. L00400, GeneScript) was
added and incubation was continued in a rotating wheel for
2 h at 4◦C. After incubation, protein A resin was washed 3
times with TBS-T (0.2%) and IP were eluted in 20 µl of 2 ×
SDS loading solution, resolved on SDS-PAGE and transferred
to PVDF membranes. ANKRD55 001 was detected in the IPs
with anti-ANKRD55 (Cat. No. HPA051049; 1:500; from Sigma-
Aldrich). 14-3-3 with anti-14-3-3 (pan) (Cat. No. 8312; 1:1,000;
fromCell Signaling). RPS3 with anti-RPS3 (Cat. No. 11990-1-AP;
1:2,000; from Proteintech), and TUBB with anti-TUBB (Cat. No.
66240-1-Ig; 1:1,000; Proteintech). HRP couple protein A (Cat.
No. SA00001-18; 1:6,000) from Proteintech was used to detect
primary antibodies.
Validation by Immunocytochemistry
For colocalization studies of endogenous and recombinant
ANKRD55 with interacting partners, HEK293 cells were plated
on coverslips coated with poly-D-lysine (Sigma-Aldrich) and
transfected with ANKRD55 001 using MACsfectin Reagent
(Miltenyi Biotec) according to manufacturer’s instructions. 24
and 48 h later, cells were fixed with 4% paraformaldehyde in
PBS for 20min at RT. Those coverslips destined to nuclear
colocalization were subjected to antigen retrieval treatment by
incubating the cells with R-Universal buffer (Cat. No. AP0501-
500; Aptum). Next cells were permeabilized with 0.2% Triton
X-100 in PBS for 30min and blocked with 3% BSA (all from
Sigma-Aldrich) in PBS for 30min. Staining was performed
with anti-ANKRD55 rabbit polyclonal (1:100), anti-RPS3 mouse
monoclonal (Cat. No. 66046-1-Ig; 1:500), anti-TUBB mouse
monoclonal (1:200), anti-VIM mouse monoclonal (Cat. No.
60330-1-Ig; 1:200), anti-14-3-3 mouse monoclonal (Cat. No.
66061-1-Ig; 1:50), and/or anti-FLAG rabbit polyclonal (Cat.
No. 20543-1-AP; 1:200), all from Proteintech for 1 h at RT,
followed by staining with Alexa Fluor 647 conjugated anti-
rabbit (ab150075; 1:500) and DyLight 550 conjugated anti-mouse
(ab98713; 1:500) from Abcam for 1 h at RT and counter-staining
with DAPI (1:500; Sigma-Aldrich). Images were obtained using
a Leica TCS CW SP8 STED Super-Resolution microscope with a
63x immersion objective and excitation wavelengths of 405, 551,
and 650 nm.
Quantification of Colocalization
For the cytoplasmatic colocalization, quantification was
carried out using LAS AF (Leica Application Suite Advanced
Fluorescence) software and Pearson’s correlation coefficient.
First, the background signal was extracted in all the studied
images. Then, the Pearson’s correlation coefficient values from
10 regions of interest (ROIs) were annotated, corresponding
each ROI to a unique cell (n = 10 cellular ROIs/condition). In
transfected cells the ROIs were selected from transfected cells.
Analysis of the colocalization quantification was performed with
GraphPad v.6 (GraphPad Software, San Diego, CA, USA). The
data is represented as mean ± SEM and the Mann–Whitney test
was applied. The level of significance was set at p ≤ 0.05, with p
≤ 0.0001 (∗∗∗∗) as extremely significant, p ≤ 0.001 (∗∗∗) highly
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significant, p ≤ 0.01 (∗∗) very significant, p ≤ 0.05 (∗) significant,
and p > 0.05 (ns) not significant.
Validation by Western Blot
ANKRD55 isoforms in immunoblots were detected by
anti-ANKRD55 rabbit polyclonal (1:500), anti-FLAG rabbit
polyclonal (1:1,000), anti-RPS3 mouse monoclonal (1:2,000),
anti-CLTC mouse monoclonal (Cat. No. 66487-1-Ig; 1:1,000),
anti-VIM mouse monoclonal (1:1,000), anti-TUBB mouse
monoclonal (1:5,000) and anti-SMC1A rabbit polyclonal
(Cat. No. 21695-1-AP; 1:500) from Proteintech; anti-SMC3
rabbit monoclonal (Cat. No. 5696; 1:2,000), anti-14-3-3 pan
(1:1,000) from Cell Signaling Technology; anti-PRKDC mouse
monoclonal (Cat. No. NBP2-22128SS; 1:1,000) and anti-HIF1AN
rabbit polyclonal (Cat. No. NB100-428; 1:1,000) from Novus
Biologicals and subsequently with HRP-conjugated anti-rabbit
(Cat. No. 111-035-144; 1:5,000) or anti-mouse (Cat. No.
715-035-150; 1:3,000) from Jackson Immunoresearch and
anti-rat (Cat. No. 7077; 1:3,000) from Cell Signaling Technology
secondary antibodies for 1 h at RT. The membranes were
incubated with clarity Western ECL Substrate (Bio-Rad) for
chemiluminescent signal detection using ChemiDoc camera
(Bio-Rad). Anti-GAPDHmouse monoclonal (Cat. No. MAB374;
1:1,000) fromMerck Millipore, anti-histone H3 rabbit polyclonal
(Cat. No. 9715; 1:1,000) from Cell Signaling Technology, and
anti-GRP94 rat monoclonal (Cat. No. ADI-SPA-850-D; 1:1,000)
from Enzo Life Sciences Abs were used to validate cell fraction
purity (Figure 1).
Bioinformatics Analysis
ANKRD55 phosphosites were identified in silico using several
tools: (i) PhosphoSitePlus (35) and dbPAF (36) databases were
consulted to look for any ANKRD55 phosphosites described
in scientific literature or public databases, and (ii) 14-3-3-Pred
web server (37) was used to predict putative 14-3-3 binding
phosphosites on ANKRD55 by combining predictions from
three different classifiers: ANN—Artificial Neural Network (cut-
off = 0.55), PSSM—Position-Specific Scoring Matrix (cut-off
= 0.80), and SVM—Support Vector Machine (cut-off = 0.25).
The ability of ANKRD55 for binding to nucleotides, DNA
and RNA was analyzed using the following web-servers: (i)
DRNApred (http://biomine.cs.vcu.edu/servers/DRNApred) (38)
for the prediction of DNA and RNA-binding proteins and
(ii) NsitePred (http://biomine.ece.ualberta.ca/nSITEpred/) (39)
predicted binding residues from the protein sequence for ATP,
ADP, AMP, GTP, and GDP.
RESULTS
Overexpressed ANKRD55 Isoforms Are
Located in Cytosol, Membranous
Organelles and Nucleus
Human ANKRD55 001 and 005 isoforms were transiently
overexpressed in HEK293 and HeLa cells, and cells were
fractionated into three subcellular compartments; cytosol (C),
nucleus (N) and membranous organelles (MO). In transfected
HEK293 cells, similar levels of isoform 005 were detected in
FIGURE 1 | Subcellular localization of recombinant ANKRD55 isoforms in
HEK293 and HeLa cells. (A) HEK293 and (B) HeLa cells were transfected with
vectors expressing either isoform 001 or 005 of ANKRD55 or left
untransfected (negative control). Cells were fractionated at 48 h after
transfection. ANKRD55 was detected with specific Ab (Sigma-Aldrich) by WB.
Enrichment for subcellular fractions was verified using histone H3 as nuclear
marker (N), GRP94 as marker of membranous organelles (MO) and GAPDH as
cytosolic marker (C). Specific bands corresponding to overexpressed isoforms
001 and 005 are indicated by black and white arrowheads, respectively. Black
cross marks endogenous ANKRD55 isoform 001. Black diamonds, and black
and white triangles show three different types of truncated immunoreactive
products.
the three fractions. Isoform 001 (72 kDa) showed a more
abundant signal than 005 (43 kDa), and was as well present
in the three compartments though slightly less abundant in
the cytosol than in the other two fractions (Figure 1). In HeLa
cells, isoform 001-enriched fraction from the cytosol showed a
stronger signal than that of the other two fractions. Isoform
005 detection was slightly weaker in nuclei than in the rest
of the fractions. Moreover, truncated immunoreactive products
were present. These included (i) a 55-60-kDa band in HEK293
and HeLa cells in isoform 001-transfected cells present in all
3 compartments though at levels differing from the full-length
proteins, (ii) a 20-kDa band in MO of HEK293 cells, and
(iii) a series of bands with Mr<34 kDa especially enriched
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in the cytosol of isoform-005 transfected HEK293 and HeLa
cells. Additionally, the results showed the endogenous isoform
001 in both cell lines demonstrating the intrinsic capacity of
HEK293 and Hela cells to produce ANKRD55 and therefore
to engage its biological pathway(s). Thus, western blot analysis
of biochemically fractionated cells revealed presence of the
isoforms 001 and 005 of ANKRD55 in all three analyzed
subcellular compartments of both cell lines (Figure 1). Further
experiments showed that it was possible to efficiently purify
ANKRD55 isoform 001, more so than isoform 005, using anti-
FLAG agarose from MO fraction, nuclear (NE) and total (TPE)
protein extracts in the presence or absence of cross-linker DSP
(Supplementary Figure 1).
Identification of Proteins in Bands
Co-purifying With ANKRD55 Isoforms 001
and 005
FLAG ANKRD55 IP from MO fraction, TPE and NE
were separated by SDS-PAGE and gels were silver stained.
Numerous specific bands were visualized in FLAG-ANKRD55
001 and 005 IP that were not present in control samples
(see examples in Supplementary Figure 2). Use of the cross-
linker DSP had generally little effect on overall intensities
of the bands, suggesting that the interaction with ANKRD55
was unaffected by lysis and purification conditions. Bands
corresponding to the Mr of recombinant FLAG-ANKRD55
isoforms and those not present in the control samples were
cut, trypsin digested and identified by nLC-MS/MS analysis
(Supplementary Table 1). Proteins belonging to the 14-3-3
family (YWHAE, YWHAZ, YWHAH, YWHAB, YWHAQ,
YWHAG) were repeatedly identified in IPs of ANKRD55 001
or 005 from TPE but not those from NE or MO extracts.
Heat shock proteins (HSPA9, HSPA5, HSPA1A, HSP90B1,
HSP90AB1, HSP90AA1, HSPA8, HSPD1) were also abundant
among ANKRD55 interactors especially so in the MO fraction.
HSP90AB1, HSP90AA1 and the unique HSP90 ER homolog
GRP94 (HSP90B1) were identified in ANKRD55 IPs from MO
fractions of bothHEK293 andHeLa cells. Members of the tubulin
superfamily were found in ANKRD55 001 IPs from TPE and
NE but not MO (TUBB, TUBA1B, TUBB4B, TUBB4A). Proteins
participating in initiation and elongation phases of eukaryotic
translation (EEF1A1, EIF4A1, TUFM, EIF4A3, EEF1G, EEF2)
were identified in all extracts. Members of the mitochondrial
FIGURE 2 | Isolation and identification of ANKRD55 interactome components by nLC-MS/MS. (A) Recombinant ANKRD55 isoform (001) was detected in nuclear
extracts (NE), total protein extracts (TPE) and eluted fractions (FLAG IP) with FLAG Ab by WB. As negative control, cells were cultivated under the same conditions,
but without transfection agent (CTRL). (B) A SYPRO Ruby-stained SDS-PAGE showing analysis strategy of ANKRD55 complexes IP with FLAG resin from NE and
TPE of HEK293 cells expressing isoform 001. ANKRD55 band or corresponding position (CTLR) is indicated with orange rectangle, while black rectangles show
contiguous gel slabs processed for mass spec. WB and SDS-PAGE are representative of three independent biological replicates. (C) Venn diagram shows numbers of
unique and shared interactors in each independent replicate (R1, R2, and R3) out of three performed for ANKRD55 IP from TPE and NE.
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transporter family SLC25 (SLC25A1, SLC25A5, SLC25A6) were
identified in TPE and MO extracts. YWHAE was identified in
presence or absence of cross-linker as well as in two independent
experiments from HEK293 TPE. The protein kinase PRKDC was
found in three independent experiments in HEK293 NE. Thus,
this first analysis revealed that ANKRD55 interacts (in)directly
with a combination of functionally distinct proteins in MO,
NE and TPE. Of these, 14-3-3 proteins appear to present the
TABLE 1 | Identification of the top twenty-two ANKRD55-interacting partners from total protein extracts and nuclear extracts from HEK293 cells, ranked by NSAF value.
Gene symbol Accession MW (kDa) Protein NSAF
ANKRD55 CTRL
Total protein extracts YWHAE P62258 29.17 14-3-3 protein epsilon 2.64 0.21
YWHAB P31946 28.082 14-3-3 protein beta/alpha 1.14 0.00
SLC25A5 P05141 32.852 ADP/ATP translocase 2 1.08 0.06
YWHAH Q04917 28.219 14-3-3 protein eta 0.97 0.00
RPS3 P23396 26.688 40S ribosomal protein S3 0.81 0.26
YWHAG P61981 28.3 14-3-3 protein gamma 0.81 0.00
TUBB6 Q9BUF5 49.857 Tubulin beta-6 chain 0.76 0.00
SLC25A11 Q02978 34.062 Mitochondrial 2-oxoglutarate/malate carrier protein 0.66 0.08
NTPCR Q9BSD7 20.713 Cancer-related nucleoside-triphosphatase 0.57 0.00
RPS15A P62244 14.84 40S ribosomal protein S15a 0.53 0.00
SLC25A13 Q9UJS0 74.176 Calcium-binding mitochondrial carrier protein Aralar2 0.47 0.00
RPL9 P32969 21.863 60S ribosomal protein L9 0.46 0.00
ARF4 P18085 20.511 ADP-ribosylation factor 4 0.46 0.00
CCT4 P50991 57.924 T-complex protein 1 subunit delta 0.43 0.12
PGAM5 Q96HS1 32.004 Serine/threonine-protein phosphatase PGAM5, mitochondrial 0.40 0.06
MCM7 P33993 81.308 DNA replication licensing factor MCM7 0.39 0.00
PCBP2 Q15366 38.58 Poly(rC)-binding protein 2 0.39 0.00
PCBP1 Q15365 37.498 Poly(rC)-binding protein 1 0.37 0.00
TIMM50 Q3ZCQ8 39.646 Mitochondrial import inner membrane translocase subunit TIM50 0.37 0.00
RPL23 P62829 14.865 60S ribosomal protein L23 0.34 0.00
PPP3CA Q08209 58.688 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform 0.34 0.00
PCNA P12004 28.769 Proliferating cell nuclear antigen 0.33 0.00
Nuclear extracts VIM P08670 53.65 Vimentin 1.11 0.19
PHB2 Q99623 33.296 Prohibitin-2 1.03 0.08
DDX3X O00571 73.243 ATP-dependent RNA helicase DDX3X 0.81 0.11
PGAM5 Q96HS1 32.004 Serine/threonine-protein phosphatase PGAM5, mitochondrial 0.81 0.00
TUBA1C Q9BQE3 49.895 Tubulin alpha-1C chain 0.73 0.00
RPS3 P23396 26.688 40S ribosomal protein S3 0.64 0.00
SMC1A Q14683 143.23 Structural maintenance of chromosomes protein 1A 0.60 0.02
DDX21 Q9NR30 87.344 Nucleolar RNA helicase 2 0.58 0.00
ATAD3A Q9NVI7 71.369 ATPase family AAA domain-containing protein 3A 0.57 0.04
SMC3 Q9UQE7 141.54 Structural maintenance of chromosomes protein 3 0.49 0.02
PRKDC P78527 469.089 DNA-dependent protein kinase catalytic subunit 0.46 0.04
NXF1 Q9UBU9 70.182 Nuclear RNA export factor 1 0.40 0.04
RUVBL1 Q9Y265 50.22 RuvB-like 1 0.36 0.00
RBM14 Q96PK6 69.492 RNA-binding protein 14 0.32 0.03
AIFM1 O95831 66.901 Apoptosis-inducing factor 1, mitochondrial 0.30 0.00
ELAVL1 Q15717 36.092 ELAV-like protein 1 0.29 0.00
IRS4 O14654 133.768 Insulin receptor substrate 4 0.24 0.00
WDR6 Q9NNW5 121.725 WD repeat-containing protein 6 0.22 0.00
NUP205 Q92621 227.922 Nuclear pore complex protein Nup205 0.19 0.01
NUP160 Q12769 162.121 Nuclear pore complex protein Nup160 0.16 0.00
PDCD11 Q14690 208.701 Protein RRP5 homolog 0.09 0.00
RANBP2 P49792 358.199 E3 SUMO-protein ligase RanBP2 0.09 0.00
The rest of ANKRD55-interacting proteins identified from total protein extracts using nLC-MS/MS are listed in Supplementary Table 2.
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best-resolved interactors in silver-stained gels (various examples
in Supplementary Figure 2).
The ANKRD55 Interactome
We compared and analyzed in more detail ANKRD55 and
control IPs in order to search for and identify additional
interacting partners as well as to confirm those identified above.
In essence, rather than focusing on single visualized gel bands,
we analyzed the complete gel lanes corresponding to ANKRD55
001 or mock (not transfected cells) FLAG eluates. Low abundant
ANKRD55-interacting proteins may be present that are not
resolved as single bands, and therefore could be missed by the
first method. Together such bands tend to produce a darker
stainable protein smear in ANKRD55 compared to mock lanes
(several such examples can be seen in Supplementary Figure 2).
By subtracting the “mock proteome” from the ANKRD55
proteome, a specific and comprehensive ANKRD55 interactome
can be deduced. We focused this proteomic analysis on FLAG-
tagged ANKRD55 isoform 001, which was more efficiently
IPed than isoform 005, and showed highest number of
potential interacting partners. FLAG-ANKRD55 isoform 001
was overexpressed in HEK293 cells and IPed from TPE and
sucrose gradient-purified NE in triplicates (three independent
experiments each that were performed on distinct days from
distinct batches of cells).WBwith FLAG antibody was performed
to verify the quality of ANKRD55 overexpression and IP
(Figure 2A). ANKRD55 complexes were then separated by SDS-
PAGE, and stained using SYPRO Ruby. The full gel lanes starting
from the boundary of the stacking gel with the resolving gel up to
the gel front were cut into ten pieces (one contained ANKRD55
001 or its control), trypsin digested, and identified by nLC-
MS/MS (Figure 2B). To build the ANKRD55 interactome, all
potential ANKRD55 interacting partners were filtered according
to their spectral count enrichment. Spectral counting accounts
for the total number of MS/MS spectra matching to peptides that
belong to a certain protein, and provides a valuable parameter
for relative protein abundance comparison (see section Materials
and Methods for more details). We identified enrichment of
148 proteins in TPE and 22 proteins in NE over the three
replicates, based on stringent selection criteria including both at
least two unique peptides and a 5-fold increase in ANKRD55
spectral counts in the ANKRD55 IP compared to control IP in
all three replicates. Several of these proteins were selected for
further functional analysis and validation (Figure 2C, Table 1,
Supplementary Table 2). The average NSAF of these proteins
was calculated in order to estimate their relative abundance
within the IPed samples. Although not considered for further
analyses, an additional, less robust, dataset of putative ANKRD55
interactors was substracted in addition to the set of reliably
enriched proteins. For this purpose, proteins enriched with
a more relaxed criteria of ANKRD55 IP/negative control IP
spectral count ratio of at least 5 in only 2 out of 3 replicates
were selected, providing additional 144 putative-ANKRD55
partners in total protein extracts and 34 in nuclear extracts
(Supplementary Table 3).
Bioinformatic Analysis of ANKRD55
Protein Partners
To interpret the potential functional role of
ANKRD55-interacting proteins, ANKRD55 interactome
FIGURE 3 | Functional enrichment analysis of ANKRD55 interactome from total protein extracts. The algorithm DAVID was used to analyze the ANKRD55 interactome
using the GO terms Cellular Component (blue), Biological Process (green), Molecular Function (orange) and Up Keywords (yellow). The GO and other terms with
FDR<5% are shown. Plotted as -log (p-value) significance.
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FIGURE 4 | Functional enrichment analysis of ANKRD55 interactome from nuclear extracts. The algorithm DAVID was used to analyze the ANKRD55 interactome
using the GO terms Cellular Component (orange), Biological Process (blue), Molecular Function (gray) and Up Keywords (yellow). The GO and other terms with
FDR<5% are shown. Plotted as –log (p-value) significance.
results were subjected to enrichment analysis using DAVID
bioinformatics resource tool. We used functional annotation
clustering to select the interesting Gene Ontology (GO) and
other terms. The results from GO biological process, GO
cellular compartment, GO molecular function and Uniprot (UP)
keywords with a FDR<5% are shown in Figures 3, 4. A more
detailed summary of the functional annotation clustering with p
< 10−3 is provided in Supplementary Table 4. The functional
analysis suggested that ANKRD55 protein partners from total
protein extracts are tightly related to nucleotide and ATP
binding (p < 1.18 × 10−13). Bioinformatics analysis predicted
the binding ability of ANKRD55 to DNA, ATP, ADP and GTP
nucleotides, but not to RNA (Supplementary Table 5). GO
categories were enriched in nuclear transport terms including
Ran GTPase binding, intracellular protein transport, protein
import into nucleus and nuclear pore (p < 2.00 × 10−03).
Total protein extracts dataset was also linked to processes that
are associated with cell cycle and RNA, lipid and amino acid
metabolism. Additionally, bioinformatics identified protein
biosynthesis-related terms such as translation, structural
constituent of ribosome, SRP-dependent cotranslational protein
targeting to membrane, tRNA aminoacylation for protein
translation and regulation of translational fidelity. GO cellular
component annotated focal adhesion, ribosome, nuclear pore,
and nuclear chromosome, among others, as the localization
of the involved proteins in the total protein interactome. In
the enrichment analysis of the ANKRD55-protein partners
from nuclear extracts, ∼20 and 30% of proteins are related
to sumoylation and RNA binding, respectively. GO categories
were involved in processes that are associated with cell cycle
including cell division, mitotic nuclear envelope disassembly,
mitosis, DNA repair and damage. Nuclear extracts interactome
was also linked to processes including RNA transport, nucleotide
and ATP binding, among others. GO cellular component
analysis indicated nuclear pore as the localization of the involved
proteins in the nuclear interactome. To further examine the
ANKRD55 interactome, we performed an Ingenuity Pathway
Analysis (IPA, QIAGEN) to identify major canonical pathways
associated with ANKRD55-interacting proteins. Sixty out of
one hundred ninety-six pathways were significantly enriched in
total protein extracts (p < 0.05; –log (p-value) > 1.30). The top
ten pathways, ranked by significance included tRNA Charging,
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FIGURE 5 | Validation of ANKRD55 isoform 001 interacting proteins. Overexpressed FLAG-ANKRD55 isoform 001 (001) associated with endogenous candidate
proteins was IPed from (A,B) total protein extracts (TPE) and from (C) enriched nuclear fractions (NE), both obtained from HEK293 cells, as well as from (D) TPE of
HeLa cells, after 48 h of transfection. As negative control cells were cultivated under the same conditions, but without transfection agent (CTRL). Recombinant
ANKRD55 and endogenous proteins were detected by WB in NE, TPE and eluted fractions (FLAG IP) using FLAG Ab and antibodies specific for interacting partners
identified by mass spec.
EIF2 Signaling, Regulation of eIF4 and p70S6K Signaling, RAN
Signaling, mTOR Signaling, Cell cycle: G2/M DNA Damage
Checkpoint Regulation, HIPPO Signaling, Cell Cycle Control
of Chromosomal Replication, PI3K/AKT Signaling and p70S6K
Signaling. In nuclear extract interactome analysis, SMC1A and
SMC3 proteins were related to Mitotic Roles of Polo-Like Kinase
and ATM Signaling; PRKDC and PHB2 to Estrogen Receptor
Signaling, VIM and TUBA1C to 14-3-3-mediated Signaling
and PRKDC and TUBA1C to Sirtuin Signaling Pathway. All
information on the IPA canonical pathways analysis of both
interactomes is included in Supplementary Table 6.
Validation of Selected ANKRD55
Interacting Partners by IP and Reverse IP
We confirmed the interaction of a selection of identified
proteins with recombinant ANKRD55 isoform 001 by IP
followed by WB using antibodies against the selected partners
(Supplementary Table 7). From the cytosolic interactome, we
selected (i) six of the first ten proteins ranked according to
NSAF value (14-3-3 isoforms YWHAE, YWHAB, YWHAH
and YWHAG, RPS3, and TUBB6); (ii) CLTC with a lower
NSAF value which is mainly localized to coated vesicles and
coated pits, in addition to cytosol and mitotic spindle; and
(iii) proteins that were found to be present as well in the
nuclear interactome (SMC1A and PRKDC). From the nuclear
interactome, three proteins (VIM, SMC1A and SMC3) from
the top ten in the list were analyzed. Several of these proteins
had at first been identified in individual bands cut from
silver-stained gels including PRKDC, SMC1A and SMC3 (see
Supplementary Table 1). For detection of TUBB6, we used
an anti-β-tubulin antibody capable of recognizing different β-
tubulin isoforms including TUBB3, TUBB2B, TUBB, TUBB4B,
TUBB2A, and TUBB4A (three of these were identified in two
out of three interactome replicates, and several of these had
been identified as well as in individual bands analyzed in
the first approach, see Supplementary Table 1). Anti-FLAG IP
experiments and WB demonstrated that endogenous SMC1A,
TUBB6, RPS3, 14-3-3 isoforms, PRKDC, CLTC in total protein
extracts (Figures 5A,B) and SMC1A, SMC3, VIM in nuclear
extracts interacted specifically with ANKRD55 isoform 001
(Figure 5C). Neither ANKRD55 nor interacting partners were
detected in the control IP. The IP of FLAG-ANKRD55 with 14-3-
3 isoforms and PRKDCwas also validated in total protein extracts
of HeLa cells by WB (Figure 5D).
We performed also reverse IP using antibodies against 14-3-
3 epsilon, the highest scoring partner of ANKRD55 in terms of
NSAF value (Table 1), RPS3 and TUBB (Figure 6). Recombinant
ANKRD55 was detected in the IPs of the specific antibodies
but not in the IgG control IPs confirming that interactions of
ANKRD55 with the target proteins were specific. We could not
detect ANKRD55 in IPs from untransfected cells, likely due to
the low levels of endogenous protein (Figure 1).
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FIGURE 6 | Detection of ANKRD55 in reverse immunoprecipitates of RPS3,
14-3-3ε and β-tubulin. RPS3 (A), 14-3-3ε (B), and β-tubulin (C) were
immunoprecipitated from HEK293 transfected with ANKRD55 (001) vector or
left untransfected (CTRL). Mock IPs were performed with control IgG
antibodies as described in the Materials and Methods. IPs were resolved on
SDS-PAGE, blotted and ANKRD55 was detected by means
of anti-ANKRD55 Ab.
We checked freely available protein-protein databases
(BioGRID (40), STRING (41) and HuRI1) to confirm some of
the identified interactions. The BioPlex 2.0 dataset (42, 43),
which has been deposited into the BioGRID database,
described thirteen ANKRD55-interacting partners; seven
were included in at least two out of three replicates from
our interactome analysis (YWHAE, YWHAQ, IFT52, IFT74,
MIB1, YWHAZ, and YWHAG). Intriguingly, HIF1AN, an
ANKRD55-interacting partner described in the BioPlex 2.0
dataset, catalyzes hydroxylation of highly conserved asparaginyl
residues within AR of NFKB1, NFKBIA, NOTCH1, ASB4,
PPP1R12A and several other AR-containing proteins (44).
1http://interactome.baderlab.org/
Therefore, this could suggest that hydroxylation of asparaginyl
residues from ANKRD55 may take place. However, in our
experimental set-up, we did not clearly detect HIF1AN
in ANKRD55 interactomes by mass spectrometry, and
neither were we able to demonstrate clearly its interaction
with ANKRD55 by WB analysis using specific antibodies
(Supplementary Figure 3). STRING database also included
ANKRD55-partners shared with our interactome, specifically
RPS3 and ACLY in Homo sapiens and Rps3 and Hsp90ab1
in Mus Musculus. Human Reference Protein Interactome
Project (HuRI) included thirty unpublished ANKRD55-
interacting partners; none of these were classified in our
protein list (Supplementary Table 8). However, some of the
HuRI ANKRD55 partners are involved in ciliogenesis and its
regulation (CFAP206, LRGUK, and DEUP1), just as are some
proteins from our ANKRD55 interactome (MIB1, IFT74, ARF4,
CCT4, CCT8, TTC26, FLNA, and IFT52), and ANKRD55
itself was described as a novel intraflagellar transport complex
protein (45). Moreover, the BioGRID database also identified
other members included in the same process (IFT46, TTC30A,
and TTC30B).
Immunofluorescence (IF) Colocalization of
ANKRD55 and Partners
Proteins that interact tend to reside within the same or adjacent
subcellular compartments (46). Fluorescence colocalization
microscopy can thus be used to assess potential links between
distinct molecules (47). Subcellular localization of endogenous
and recombinant ANKRD55 using anti-ANKRD55 Ab with
a selection of interacting partners was analyzed to verify
sharing of specific subcellular localizations. Under conditions
used for visualization, anti-ANKRD55 antibody detected
ANKRD55 in transfected cells but not in untransfected
cells (Supplementary Figure 4). However, endogenous
ANKRD55 could be visualized in untransfected cells using over-
/underexposure Look-up Table scale (Supplementary Figure 5).
In the IF Figures, we include the Pearson’s correlation coefficient
for colocalization of RPS3, TUBB, 14-3-3 and VIM with both
endogenous ANKRD55 (Untrans.) and recombinant ANKRD55
(Trans.) at 24 and 48 h after transfection (B panels in Figures 7–
9, Supplementary Figure 6). The results showed a highly
significant colocalization (p ≤ 0.001) between recombinant
ANKRD55 isoform 001 and either RPS3 (Figure 7) or β-tubulin
isoforms (Figure 8) in both the cytoplasm and cell membrane.
Correlation of colocalization between 14-3-3 and ANKRD55
was not higher with recombinant ANKRD55 (Figure 9) than
with the endogenous one, and that with VIM only increased
at 48 h (Supplementary Figure 6), suggesting already-high
occupancy of these proteins with the endogenous ANKRD55.
Recombinant ANKRD55 colocalization with β-tubulin and
14-3-3 isoforms remained constant, but decreased over time
after transfection with RPS3 (Figures 7–9) and increased
with VIM (Supplementary Figure 6). As shown in Figures 7,
8 ANKRD55 was poorly detectable in the nucleus, despite
its presence in biochemically or sucrose-gradient obtained
nuclear fractions (Figure 2). The procedure was modified to
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FIGURE 7 | Recombinant ANKRD55 isoform 001 colocalizes with endogenous RPS3 in HEK293 cells. (A) Representative microphotographs of immunostaining for
ANKRD55 (anti-ANKRD55 Ab; red), 40S ribosomal protein S3 (RPS3 Ab; green) and nuclei (DAPI; white) in untransfected (Untrans.) and transfected (Trans. 24h or
48h) HEK293 cells with ANKRD55 isoform 001. (B) Colocalization quantification using Pearson’s correlation coefficient. Data are mean ± SEM (n = 10 cellular
ROIs/condition), p ≤ 0.0001 (****) and p ≤ 0.001 (***) comparing three conditions, Mann-Whitney test.
include an antigen retrieval treatment step to try to increase the
fluorescent signal of the nuclei. This modification was successful
when used in combination with a highly sensitive anti-FLAG
Ab and was applied to study the nuclear colocalization of
overexpressed ANKRD55 together with β-tubulin isoforms
(Figure 10) and VIM (Supplementary Figure 7). After antigen
retrieval treatment, recombinant ANKRD55 became visible in
the nuclei of cells in division, though these cells exhibited
a lower fluorescence intensity signal than not-dividing
cells. Quantification was not performed due to the small
sample size. ANKRD55 positively colocalized with diffuse
β-tubulin isoforms in the nucleus and specifically with the
mitotic spindle (Figure 10). It also colocalized with diffuse
VIM in the nucleus without an associated specific structure
(Supplementary Figure 7).
ANKRD55 Is a Phosphoprotein
An important subset of proteins identified in this interactome
analysis belong to the 14-3-3 protein family. 14-3-3 proteins
are ubiquitously expressed phosphoserine/phosphothreonine
(pS/pT)-binding proteins that are members of a large family
of isoforms (48). In general, they bind to their ligands
through RSXpS/TXP or RXXXpS/TXP sequences (49), but they
can also bind their ligands in a phosphorylation-independent
manner (50, 51). Thus, we determined whether ANKRD55
was phosphorylated. Our primary sources for this step were
phosphoproteome repositories, such as PhosphoSitePlus (35) and
dbPAF (36) databases. Moreover, 14-3-3-Pred web server (37)
was used to predict putative 14-3-3 binding phosphosites on
ANKRD55. Two out of ninety predicted phosphorylation sites
(S436 and S597) fulfill the cut-off (Supplementary Table 9). We
identified specific serine and threonine phosphorylation sites
in overexpressed and immunoprecipitated ANKRD55 isoform
001 from HEK293 nuclear and total proteins extracts by
TiO2-based phosphopeptide enrichment prior to nLC–MS/MS
analysis. The phosphorylation sites at T6 and S436 in ANKRD55
were confirmed and the S475 site was found in nuclear and
total protein extracts previously identified in mouse ANKRD55
(Table 2). In conclusion, the data revealed five phosphorylation
sites in human ANKRD55 at T6, T11, T189, S436 and S475. 14-3-
3-Pred web server predicted with the highest score S436 as 14-3-3
binding phosphosite.
DISCUSSION
ANKRD55 emerged as the nearest annotated gene of which
expression is affected by a series of cis-eQTL risk SNPs that
were identified through multiple GWAS and other studies
in diverse multifactorial—predominantly autoimmune, diseases
(1–17). However, the biological function(s) of ANKRD55 has
(have) not been elucidated. Ankyrin repeats function as versatile
scaffolds for protein–protein interactions. ANKRD55 isoform
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FIGURE 8 | Recombinant ANKRD55 isoform 001 colocalizes with endogenous β-tubulin in HEK293 cells. (A) Representative microphotographs of immunostaining
for ANKRD55 (anti-ANKRD55 Ab; red), tubulin beta chain (TUBB Ab; green) and nuclei (DAPI; white) in untransfected (Untrans.) and transfected (Trans. 24 h or 48 h)
HEK293 cells with ANKRD55 isoform 001. (B) Colocalization quantification using Pearson’s correlation coefficient. Data are mean ± SEM (n = 10 cellular
ROIs/condition), p ≤ 0.0001 (****), and not significant (ns) comparing three conditions, Mann-Whitney test.
001, the main focus of this study, contains nine ankyrin repeats
and consequently should take part in diverse PPIs as has
been reported for other members of the ANK family (21–27).
Similar to naturally produced ANKRD55 (18), overexpressed
recombinant ANKRD55 is present in the nuclei and cytosol. We
therefore characterized the ANKRD55 protein interactome from
both TPE and sucrose-gradient-purified NE. The limitations
of using co-immunoprecipitation in overexpressing cell lines
to determine protein interactions should be noted, as this
approach may lead to non-specific interactions and prevents
spatial or temporal analysis of protein interactions (61). A
larger group of ANKRD55-interacting partners was present in
total protein extracts than in nuclear extracts with 148 vs. 22
proteins consistently identified over three independent replicates.
Functional analysis suggested that ANKRD55-protein partners
from nuclear (eight and seven proteins) and total protein extracts
(fifty-two and forty-three proteins) are related to nucleotide and
ATP binding, respectively. 30% of proteins from the nuclear
interactome are related to RNA binding.
Experiments were performed to validate top-scoring partners
of ANKRD55 by western blot, reverse IP and/or colocalization in
IFmicroscopy. Four distinct 14-3-3 proteins (epsilon, beta/alpha,
eta and gamma) were identified in total cell extracts. 14-3-3
colocalized with ANKRD55 in IF microscopy, and ANKRD55
was detected in reverse IP of 14-3-3ε, the major ANKRD55
partner (Table 1). Being pS/pT-binding proteins, their presence
led us to identify and confirm five phosphorylation sites in
ANKRD55 with S436 as most likely 14-3-3 binding phosphosite.
14-3-3 proteins modulate the action of proteins that are involved
in cell cycle and transcriptional control, signal transduction,
intracellular trafficking and regulation of ion channels (62)
through a variety of mechanisms: (i) direct conformational
change of the target protein; (ii) physical occlusion of sequence-
specific or structural features; and (iii) scaffolding that anchors
proteins within close proximity of one another (63).
Eleven ribosomal proteins (RPs) were identified in ANKRD55
interactomes. Of these, RPS3 was identified in both nuclear
and total protein extract interactomes as one of the top
10 hits, and was confirmed by western blot of IPs and by
colocalization with ANKRD55 by IF microscopy. ANKRD55
was also detected in reverse IP of RPS3. Although RPs are
known for playing an essential role in ribosome assembly
and protein translation, their ribosome-independent functions
are also increasingly being appreciated (64). RPS3, specifically,
has been shown to induce apoptosis by collaborating with
E2F1 (65). Phospho-RPS3 translocates into the nucleus and
upregulates prosurvival gene expression via association with
NF-κB in non-small cell lung cancer cells (66, 67). RPS3 is
also involved in immune signaling by selectively modulating
NF-κB target gene expression. Given the fact that RPS3 also
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FIGURE 9 | Recombinant ANKRD55 isoform 001 colocalizes with endogenous 14-3-3 proteins in HEK293 cells. (A) Representative microphotographs of
immunostaining for ANKRD55 (anti-ANKRD55 Ab; red), 14-3-3 (14-3-3 Ab; green) and nuclei (DAPI; white) in untransfected (Untrans.) and transfected (Trans. 24 h or
48 h) HEK293 cells with ANKRD55 isoform 001. (B) Colocalization quantification using Pearson’s correlation coefficient. Data are mean ± SEM (n = 10 cellular
ROIs/condition), not significant (ns) comparing three conditions, Mann-Whitney test.
activates the p53 tumor suppressive pathway (68), this RP
is regarded as one of the most fascinating RP with pivotal
multifunctions (69).
ANKRD55 colocalized with TUBB in IFmicroscopy, and their
interaction was confirmed by western blot; ANKRD55 was also
identified in reverse IPs of TUBB. Inspection by IF microscopy
revealed that ANKRD55 is detectable in the nucleus mainly
during mitosis. Throughout the different phases of mitosis, β-
tubulin presented a specific marking in the mitotic spindle that
colocalized with ANKRD55. Other proteins were reproducibly
identified in the nuclear ANKRD55 interactome that have been
reported to fulfill roles associated with mitotic spindle dynamics
or structure. These include SMC3 and SMC1A that are members
of the cohesin complex that is crucial for chromatid cohesion. By
holding the two sister chromatids together from their formation
during replication until their separation in anaphase, cohesin
creates a counterforce to the pulling of the mitotic spindle, which
allows correct chromosome alignment and segregation (70). The
association between the ANKRD55-interacting proteins and the
mitotic spindle is also supported by the presence of RPS3 protein
which was reported to be involved in spindle dynamics (71).
Similarly, Ran GTPase binding, enriched in the GO analysis, has
been related to the spindle formation (72). MCM3, 6 and 7, DNA
helicases involved in the initiation of DNA replication, were also
found in ANRD55 interactomes. Of these, MCM7 is known to
co-localize with tubulin in mitotic cells with MCM7 depletion
resulting in aberrant mitosis. This is in line with observations
that MCM7 exerts certain functions on spindle formation to
prevent cytokinesis during early mitosis by regulating CDK1
activity (73).
GO categories from total protein extracts were enriched in
nuclear transport terms providing a possible explanation for
the nucleocytoplasmic transport of ANKRD55, which seems
to be mediated by the importins/exportins transport system
enriched in the interactome (CSE1L, XPO1, IPO4, XPOT,
IPO5, NUP160, NUP205, KPNA2, COPG1, CDK5, YWHAH,
CLTC). However, a number of AR-containing proteins, such
as IκBα, ASPP2, and GABPβ, have been reported to enter
the nucleus via an unknown mechanism independent of a
canonical nuclear localization signal (74). As demonstrated
by Lu et al. (75), this mechanism is characterized by the
presence of components of the RanGDP/AR pathway which
represents a general importin-independent nuclear import
pathway frequently used by AR-containing proteins (75). Ran
GTPase binding, which obtained high significance in the
GO, is known to regulate protein trafficking through the
nuclear envelope and is an active component of both nuclear
transport systems.
In conclusion, the large number of protein interactors
identified in this study suggests that ANKRD55 may act as
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FIGURE 10 | Colocalization of nuclear recombinant ANKRD55 iosoform 001 with endogenous β-tubulin in HEK293 cells following antigen retrieval treatment.
Representative microphotographs of immunostaining for ANKRD55 (FLAG Ab; red), tubulin beta chain (TUBB Ab; green) and nuclei (DAPI; white) in non-transfected
(CTRL) and transfected (24 h or 48 h) HEK293 cells with ANKRD55 isoform 001 subjected to antigen retrieval treatment. Original image included zoom-in region
(yellow), the signal intensity in zoom-in images was increased. Colocalization of ANKRD55 with TUBB in the mitotic spindle is indicated with colored triangles.
TABLE 2 | Summary of identified Ser/Thr Phosphorylation Sites in ANKRD55.
Position Peptides Species References Sources Identified phosphorylation sites
T6 MMRQAtMDFSTPS Human (52) PhosphoSitePlus N/T
T11 QATMDFStPSVFDQQ Human (52) PhosphoSitePlus
T189 GADPtLVDK Human (53) dbPAF
S436 TQsLPPITLGNNFLTASHR Human (54) dbPAF T
S473 MAQRSQKsRSEQDLL Mouse (55, 56) PhosphoSitePlus
S475 QRSQKSRsEQDLLNN Mouse (55–60) PhosphoSitePlus N/T
The first five columns show the phosphorylation sites identified in the phosphoproteome repositories including position and sequence of the peptide, species in which it was found,
reference for the experiment data and database. The last column represents our own experimental data identifying specific ANKRD55 phosphosites: N, nuclear extracts and T, total
protein extracts.
a scaffold, probably exerting function(s) in the formation or
architecture of multiple protein complexes, that may be regulated
via (de)phosphorylation reactions occurring at up to 5 sites in
the protein.
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